Citation: Af. Machado et al., Pax3 and the splotch mutations: Structure, function, and relationship to teratogenesis, including gene-chemical interactions, CUR PHARM D, 7(9), 2001, pp. 751-785
Citation: Br. Danielson et al., Class III antiarrhythmics and phenytoin: Teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage, CUR PHARM D, 7(9), 2001, pp. 787-802
Citation: Pj. Kostenuik et V. Shalhoub, Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption, CUR PHARM D, 7(8), 2001, pp. 613-635
Citation: Srj. Hoare et Tb. Usdin, Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1)and PTH2 receptors, CUR PHARM D, 7(8), 2001, pp. 689-713
Citation: Am. Hoffren et al., Structure-based focusing using pharmacophores derived from the active siteof 17 beta-hydroxysteroid dehydrogenase, CUR PHARM D, 7(7), 2001, pp. 547-566
Citation: A. Tropsha et Wf. Zhang, Identification of the descriptor pharmacophores using variable selection QSAR: Applications to database mining, CUR PHARM D, 7(7), 2001, pp. 599-612
Citation: R. Volpe, The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: A review, CUR PHARM D, 7(6), 2001, pp. 451-460